Back to search
FDAFDA · Food and drugs·Recall number D-1424-2014

Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20

Published July 16, 2014 · Recall initiated: May 16, 2014

Summary

FDA records drug Class II recall D-1424-2014, published July 16, 2014 and initiated May 16, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 45,448 vials; Lot: Lot 36225DD, exp 12/01/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution

What to do

Voluntary: Firm initiated · Press Release

Get an email if LABETALOL HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LABETALOL HYDROCHLORIDE
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 36225DD, exp 12/01/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20 recalled?

Yes. FDA published recall D-1424-2014 on July 16, 2014. Reported hazard: Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LABETALOL HYDROCHLORIDE.